{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:22:43Z","timestamp":1781835763127,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,3,29]],"date-time":"2017-03-29T00:00:00Z","timestamp":1490745600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00726-017-2413-6","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T23:47:01Z","timestamp":1490744821000},"page":"1133-1141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Genetic variations in the alanine\u2013glyoxylate aminotransferase 2 (AGXT2) gene and dimethylarginines levels in rheumatoid arthritis"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0364-1642","authenticated-orcid":false,"given":"Theodoros","family":"Dimitroulas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios F.","family":"Panoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamer","family":"Sandoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,29]]},"reference":[{"key":"2413_CR1","doi-asserted-by":"crossref","first-page":"846","DOI":"10.2337\/dc13-0546","volume":"37","author":"M Anderssohn","year":"2014","unstructured":"Anderssohn M, McLachlan S, L\u00fcneburg N, Robertson C, Schwedhelm E, Williamson RM, Strachan MW, Ajjan R, Grant PJ, B\u00f6ger RH, Price JF (2014) Genetic and environmental determinants of dimethylarginines and association with cardiovascular disease in patients with type 2 diabetes. Diabetes Care 37:846\u2013854","journal-title":"Diabetes Care"},{"key":"2413_CR2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, LA CooperNS Healey, Kaplan SR, Liang MH, Luthra HS (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"2413_CR3","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","volume":"71","author":"JA Avina-Zubieta","year":"2012","unstructured":"Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D (2012) Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 71:1524\u20131529","journal-title":"Ann Rheum Dis"},{"key":"2413_CR4","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1161\/ATVBAHA.112.254078","volume":"32","author":"B Caplin","year":"2012","unstructured":"Caplin B, Wang Z, Slaviero A, Tomlinson J, Dowsett L, Delahaye M, Salama A, International Consortium for Blood Pressure Genome-Wide Association Studies, Wheeler DC, Leiper J (2012) Alanine\u2013glyoxylate aminotransferase 2 metabolizes endogenous methylarginines, regulates NO, and controls blood pressure. Arterioscler Thromb Vasc Biol 32:2892\u20132900","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2413_CR5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.niox.2011.08.003","volume":"25","author":"K Chobanyan-J\u03ccrgens","year":"2011","unstructured":"Chobanyan-J\u03ccrgens K, Pham VV, Stichtenoth DO, Tsikas D (2011) Elevated dimethylarginine dimethylaminohydrolase (DDAH) activity in rheumatoid arthritis and spondyloarthritis. Nitric Oxide 25:436\u2013438","journal-title":"Nitric Oxide"},{"key":"2413_CR6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/ard.2008.105049","volume":"69","author":"D Daoussis","year":"2010","unstructured":"Daoussis D, Panoulas VF, Antonopoulos I, John H, Toms TE, Wong P, Nightingale P, Douglas KM, Kitas GD (2010) Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis. Ann Rheum Dis 69:517\u2013521","journal-title":"Ann Rheum Dis"},{"key":"2413_CR7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3109\/03009742.2012.747627","volume":"42","author":"T Dimitroulas","year":"2013","unstructured":"Dimitroulas T, Sandoo A, Veldhuijzen van Zanten JJ, Smith JP, Hodson J, Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD (2013) Predictors of asymmetric dimethylarginine levels in patients with rheumatoid arthritis: the role of insulin resistance. Scand J Rheumatol 42:176\u2013181","journal-title":"Scand J Rheumatol"},{"key":"2413_CR8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.atherosclerosis.2014.07.033","volume":"237","author":"T Dimitroulas","year":"2014","unstructured":"Dimitroulas T, Sandoo A, Hodson J, Smith J, Panoulas VF, Kitas GD (2014) Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis. Atherosclerosis 237:38\u201344","journal-title":"Atherosclerosis"},{"key":"2413_CR9","first-page":"62","volume":"26","author":"T Dimitroulas","year":"2015","unstructured":"Dimitroulas T, Sandoo A, Douglas K, Kitas G (2015a) Symmetric and asymmetric dimethylarginines as biochemical markers of endothelial dysfunction and atherosclerosis in Rheumatoid Arthritis Mediterr. J Rheumatol 26:62\u201375","journal-title":"J Rheumatol"},{"key":"2413_CR10","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s00726-015-1953-x","volume":"47","author":"T Dimitroulas","year":"2015","unstructured":"Dimitroulas T, Hodson J, Sandoo A, Smith J, Kitas GD (2015b) Symmetric dimethylarginine (SDMA) serum levels in rheumatoid arthritis: correlations with insulin resistance and disease activity scores. Amino Acids 47:1995\u20132004","journal-title":"Amino Acids"},{"key":"2413_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2014.09.024","volume":"27","author":"D Feliers","year":"2015","unstructured":"Feliers D, Lee DY, Gorin Y, Kasinath BS (2015) Symmetric dimethylarginine alters endothelial nitric oxide activity in glomerular endothelial cells. Cell Signal 27:1\u20135","journal-title":"Cell Signal"},{"key":"2413_CR12","doi-asserted-by":"crossref","first-page":"24412","DOI":"10.3390\/ijms141224412","volume":"14","author":"S Franceschelli","year":"2013","unstructured":"Franceschelli S, Ferrone A, Pesce M, Riccioni G, Speranza L (2013) Biological functional relevance of asymmetric dimethylarginine (ADMA) in cardiovascular disease. Int J Mol Sci 14:24412\u201324421","journal-title":"Int J Mol Sci"},{"key":"2413_CR13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2174\/138161282004140213121733","volume":"20","author":"AY Gasparyan","year":"2014","unstructured":"Gasparyan AY (2014) Autoimmunity and autoinflammation: cardiovascular drug targets and design. Curr Pharm Des 20:483\u2013485","journal-title":"Curr Pharm Des"},{"key":"2413_CR14","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1161\/ATVBAHA.113.301219","volume":"233","author":"MO Gore","year":"2013","unstructured":"Gore MO, L\u00fcneburg N, Schwedhelm E, Ayers CR, Anderssohn M, Khera A, Atzler D, de Lemos JA, Grant PJ, McGuire DK, B\u00f6ger RH (2013) Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart study. Arterioscler Thromb Vasc Biol 233:2682\u20132688","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2413_CR15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.atherosclerosis.2008.10.040","volume":"205","author":"S Kiechl","year":"2009","unstructured":"Kiechl S, Lee T, Santer P, Thompson G, Thompson G, Tsimikas S, Egger G, Holt DW, Willeit J, Xu Q, Mayr M (2009) Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population. Atherosclerosis 205:261\u2013265","journal-title":"Atherosclerosis"},{"key":"2413_CR16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbrc.2012.11.008","volume":"430","author":"A Kittel","year":"2013","unstructured":"Kittel A, Maas R, K\u00f6nig J, Mieth M, Weiss N, Jarzebska N, Hohenstein B, Martens-Lobenhoffer J, Bode-B\u00f6ger SM, Rodionov RN (2013) In vivo evidence that Agxt2 can regulate plasma levels of dimethylarginines in mice. Biochem Biophys Res Commun 430:84\u201389","journal-title":"Biochem Biophys Res Commun"},{"key":"2413_CR17","first-page":"673","volume":"14","author":"L Levy","year":"2008","unstructured":"Levy L, Fautrel B, Barnetche T, Schaeverbeke T (2008) Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature. Clin Exp Rheumatol 14:673\u2013679","journal-title":"Clin Exp Rheumatol"},{"key":"2413_CR18","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/CIRCGENETICS.113.000264","volume":"7","author":"N L\u00fcneburg","year":"2014","unstructured":"L\u00fcneburg N, Lieb W, Zeller T, Chen MH, Maas R, Carter AM, Xanthakis V, Glazer NL, Schwedhelm E, Seshadri S, Ikram MA, Longstreth WT Jr, Fornage M, K\u00f6nig IR, Loley C, Ojeda FM, Schillert A, Wang TJ, Sticht H, Kittel A, K\u00f6nig J, Benjamin EJ, Sullivan LM, Bernges I, Anderssohn M, Ziegler A, Gieger C, Illig T, Meisinger C, Wichmann HE, Wild PS, Schunkert H, Psaty BM, Wiggins KL, Heckbert SR, Smith N, Lackner K, Lunetta KL, Blankenberg S, Erdmann J, Munzel T, Grant PJ, Vasan RS, B\u00f6ger RH (2014) Genome-wide association study of l-arginine and dimethylarginines reveals novel metabolic pathway for symmetric dimethylarginine. Circ Cardiovasc Genet 7:864\u2013872","journal-title":"Circ Cardiovasc Genet"},{"key":"2413_CR19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/CS20110013","volume":"122","author":"N L\u03ccneburg","year":"2012","unstructured":"L\u03ccneburg N, von Holten RA, T\u03c6pper RF, Schwedhelm E, Maas R, B\u03c6ger RH (2012) Symmetric dimethylarginine is a marker of detrimental outcome in the acute phase after ischaemic stroke: role of renal function. Clin Sci (Lond) 122:105\u2013111","journal-title":"Clin Sci (Lond)"},{"key":"2413_CR20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"2413_CR21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2010.150854","volume":"57","author":"A Meinitzer","year":"2011","unstructured":"Meinitzer A, Kielstein JT, Pilz S, Drechsler C, Ritz E, Boehm BO, Winkelmann BR, M\u00e4rz W (2011) Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study. Clin Chem 57:112\u2013121","journal-title":"Clin Chem"},{"key":"2413_CR22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/90387","volume":"8","author":"J Murray-Rust","year":"2001","unstructured":"Murray-Rust J, Leiper J, McAlister M, Phelan J, Tilley S, Santa Maria J, Vallance P, McDonald N (2001) Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase. Nat Struct Biol 8:679\u2013683","journal-title":"Nat Struct Biol"},{"key":"2413_CR23","doi-asserted-by":"crossref","first-page":"881e3","DOI":"10.1136\/ard.2010.145839","volume":"70","author":"MT Nurmohamed","year":"2011","unstructured":"Nurmohamed MT, Kitas G (2011) Cardiovascular risk in rheumatoid arthritis and diabetes: how does it compare and when does it start? Ann Rheum Dis 70:881e3","journal-title":"Ann Rheum Dis"},{"key":"2413_CR24","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/0003-9861(87)90060-9","volume":"252","author":"T Ogawa","year":"1987","unstructured":"Ogawa T, Kimoto M, Watanabe H, Sasaoka K (1987) Metabolism of NG, NG-and NG, N\u2032G-dimethylarginine in rats. Arch Biochem Biophys 252:526\u2013537","journal-title":"Arch Biochem Biophys"},{"key":"2413_CR25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/rheumatology\/ket338","volume":"53","author":"VF Panoulas","year":"2014","unstructured":"Panoulas VF, Toms TE, Douglas KM, Sandoo A, Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD (2014) Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden. Rheumatology (Oxford) 53:131\u2013137","journal-title":"Rheumatology (Oxford)"},{"key":"2413_CR26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.tips.2014.09.005","volume":"35","author":"RN Rodionov","year":"2014","unstructured":"Rodionov RN, Jarzebska N, Weiss N, Lentz SR (2014) AGXT2: a promiscuous aminotransferase. Trends Pharmacol Sci 35:575\u2013582","journal-title":"Trends Pharmacol Sci"},{"key":"2413_CR27","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1093\/rheumatology\/ker275","volume":"50","author":"A Sandoo","year":"2011","unstructured":"Sandoo A, Veldhuijzen van Zanten JJ, Metsios GS, Carroll D, Kitas GD (2011) Vascular function and morphology in rheumatoid arthritis: a systematic review. Rheumatology (Oxford) 50:2125\u20132139","journal-title":"Rheumatology (Oxford)"},{"key":"2413_CR28","first-page":"388","volume":"30","author":"A Sandoo","year":"2012","unstructured":"Sandoo A, Dimitroulas T, Veldhuijzen van Zanten JJ, Smith JP, Metsios GS, Nightingale P, Stavropoulos-Kalinoglou A, Kitas GD (2012a) Lack of association between asymmetric dimethylarginine and in vivo microvascular and macrovascular endothelial function in patients with rheumatoid arthritis. Clin Exp Rheumatol 30:388\u2013396","journal-title":"Clin Exp Rheumatol"},{"key":"2413_CR29","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.clinbiochem.2012.07.092","volume":"45","author":"A Sandoo","year":"2012","unstructured":"Sandoo A, Dimitroulas T, Toms TE, Hodson J, Veldhuijzen van Zanten JJ, Smith JP, Kitas GD (2012b) Clinical remission following treatment with tumour necrosis factor-alpha antagonists is not accompanied by changes in asymmetric dimethylarginine in patients with rheumatoid arthritis. Clin Biochem 45:1399\u20131403","journal-title":"Clin Biochem"},{"key":"2413_CR30","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/rheumatology\/keu349","volume":"54","author":"A Sandoo","year":"2015","unstructured":"Sandoo A, Dimitroulas T, Hodson J, Smith JP, Douglas KM, Kitas GD (2015) Cumulative inflammation associates with asymmetric dimethylarginine in rheumatoid arthritis: a 6\u00a0year follow-up study. Rheumatology (Oxford) 54:1145\u20131152","journal-title":"Rheumatology (Oxford)"},{"key":"2413_CR31","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/ndt\/gfn670","volume":"24","author":"E Schepers","year":"2009","unstructured":"Schepers E, Glorieux G, Dhondt A, Leybaert L (2009) Vanholder R (2009) Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes. Nephrol Dial Transplant 24:1429\u20131435","journal-title":"Nephrol Dial Transplant"},{"key":"2413_CR32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.semnephrol.2014.02.003","volume":"34","author":"E Schepers","year":"2014","unstructured":"Schepers E, Speer T, Bode-B\u00f6ger SM, Fliser D, Kielstein JT (2014) Dimethylarginines ADMA and SDMA: the real water-soluble small toxins? Semin Nephrol 34:97\u2013105","journal-title":"Semin Nephrol"},{"key":"2413_CR33","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1530\/EJE-09-0865","volume":"162","author":"AE Schutte","year":"2010","unstructured":"Schutte AE, Schutte R, Huisman HW, van Rooyen JM, Fourie CM, Malan L, Malan NT, Schwedhelm E, Strimbeanu S, Anderssohn M, Boger RH (2010) Dimethylarginines: their vascular and metabolic roles in Africans and Caucasians. Eur J Endocrinol 162:525\u2013533","journal-title":"Eur J Endocrinol"},{"key":"2413_CR34","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/eurheartj\/eht447","volume":"35","author":"I Sepp\u00e4l\u00e4","year":"2014","unstructured":"Sepp\u00e4l\u00e4 I, Kleber ME, Lyytik\u00e4inen LP, Hernesniemi JA, M\u00e4kel\u00e4 KM, Oksala N, Laaksonen R, Pilz S, Tomaschitz A, Silbernagel G, Boehm BO, Grammer TB, Koskinen T, Juonala M, Hutri-K\u00e4h\u00f6nen N, Alfthan G, Viikari JS, K\u00e4honen M, Raitakari OT, M\u00e4rz W, Meinitzer A, Lehtim\u00e4ki T, AtheroRemo Consortium (2014) Genome-wide association study on dimethylarginines reveals novel AGXT2 variants associated with heart rate variability but not with overall mortality. Eur Heart J 35:524\u2013531","journal-title":"Eur Heart J"},{"key":"2413_CR35","doi-asserted-by":"crossref","first-page":"23207","DOI":"10.1038\/srep23207","volume":"6","author":"I Sepp\u00e4l\u00e4","year":"2016","unstructured":"Sepp\u00e4l\u00e4 I, Kleber ME, Bevan S, Lyytik\u00e4inen LP, Oksala N, Hernesniemi JA, M\u00e4kel\u00e4 KM, Rothwell PM, Sudlow C, Dichgans M, Mononen N, Vlachopoulou E, Sinisalo J, Delgado GE, Laaksonen R, Koskinen T, Scharnagl H, K\u00e4h\u00f6nen M, Markus HS, M\u00e4rz W, Lehtim\u00e4ki T (2016) Associations of functional alanine\u2013glyoxylate aminotransferase 2 gene variants with atrial fibrillation and ischemic stroke. Sci Rep 6:23207","journal-title":"Sci Rep"},{"key":"2413_CR36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00392-012-0515-4","volume":"102","author":"B Siegerink","year":"2013","unstructured":"Siegerink B, Maas R, Vossen CY, Schwedhelm E, Koenig W, B\u03c6ger R, Rothenbacher D, Brenner H, Breitling LP (2013) Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study. Clin Res Cardiol 102:193\u2013202","journal-title":"Clin Res Cardiol"},{"key":"2413_CR37","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00726-013-1556-3","volume":"45","author":"J Strobel","year":"2013","unstructured":"Strobel J, M\u00fcller F, Zolk O, Endre\u00df B, K\u00f6nig J, Fromm MF, Maas R (2013) Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1). Amino Acids 45:989\u20131002","journal-title":"Amino Acids"},{"key":"2413_CR38","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/art.22424","volume":"56","author":"A Surdacki","year":"2007","unstructured":"Surdacki A, Martens-Lobenhoffer J, Wloch A, Marewicz E, Rakowski T, Wieczorek-Surdacka E, Dubiel JS, Pryjma J, Bode-B\u00f6ger SM (2007) Elevated plasma asymmetric dimethyl-l-arginine levels are linked to endothelial progenitor celldepletion and carotid atherosclerosis in rheumatoid arthritis. Arthritis Rheum 56:809\u2013819","journal-title":"Arthritis Rheum"},{"key":"2413_CR39","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/cvr\/cvq214","volume":"87","author":"J Tamargo","year":"2010","unstructured":"Tamargo J, Caballero R, G\u00f3mez R, Delp\u00f3n E (2010) Cardiac electrophysiological effects of nitric oxide. Cardiovasc Res 87:593\u2013600","journal-title":"Cardiovasc Res"},{"key":"2413_CR40","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.2174\/0929867322666150625095046","volume":"22","author":"D Tousoulis","year":"2015","unstructured":"Tousoulis D, Georgakis MK, Oikonomou E, Papageorgiou N, Zaromitidou M, Latsios G, Papaioannou S, Siasos G (2015) Asymmetric dimethylarginine: clinical significance and novel therapeutic approaches. Curr Med Chem 22:2871\u20132901","journal-title":"Curr Med Chem"},{"issue":"742","key":"2413_CR41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0378-4347(00)00142-0","volume":"26","author":"D Tsikas","year":"2000","unstructured":"Tsikas D, Sandmann J, Savva A, Luessen P, B\u03c6ger RH, Gutzki FM, Mayer B, Fr\u03c6lich JC (2000) Assessment of nitric oxide synthase activity in vitro and in vivo by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl 26(742):143\u2013153","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"2413_CR42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5505\/tjb.2013.51523","volume":"38","author":"H Vatansev","year":"2013","unstructured":"Vatansev H, Ozturk B, Y\u0131lmaz S, Sivrikaya A, Da\u011fl\u0131 M, K\u0131y\u0131c\u0131 A (2013) Asymmetric dimethylarginine and arginine levels in patients with rheumatoid arthritis. Turk J Biochem 38:169\u2013175","journal-title":"Turk J Biochem"},{"key":"2413_CR43","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1161\/ATVBAHA.109.185645","volume":"29","author":"Z Wang","year":"2009","unstructured":"Wang Z, Tang WH, Cho L, Brennan DM, Hazen SL (2009) Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition. Arterioscler Thromb Vasc Biol 29:1383\u20131391","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2413_CR44","doi-asserted-by":"crossref","first-page":"e001833","DOI":"10.1161\/JAHA.115.001833","volume":"4","author":"P Willeit","year":"2015","unstructured":"Willeit P, Freitag DF, Laukkanen JA, Chowdhury S, Gobin R, Mayr M, Di Angelantonio E, Chowdhury R (2015) Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies. J Am Heart Assoc 4:e001833","journal-title":"J Am Heart Assoc"},{"key":"2413_CR45","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.5551\/jat.23077","volume":"21","author":"JP Zhou","year":"2014","unstructured":"Zhou JP, Bai YP, Hu XL, Kuang DB, Shi RZ, Xiong Y, Zhang W, Xia J, Chen BL, Yang TL, Chen XP (2014) Association of the AGXT2 V140I polymorphism with risk for coronary heart disease in a Chinese population. J Atheroscler Thromb 21:1022\u20131030","journal-title":"J Atheroscler Thromb"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00726-017-2413-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-017-2413-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-017-2413-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T05:10:54Z","timestamp":1495084254000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00726-017-2413-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,29]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["2413"],"URL":"https:\/\/doi.org\/10.1007\/s00726-017-2413-6","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,29]]}}}